Balaji Amines (NSE:BALAMINES) Research & Development: ₹0 Mil (TTM As of Mar. 2026)


NSE:BALAMINES Balaji Amines Ltd NSE:BALAMINES
77 GF Score
Price ₹1,989.00
GF Value ₹1,616.31
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Balaji Amines Research & Development?

Balaji Amines NSE:BALAMINES -4.22% 77 Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:BALAMINES with a GF Score™ of 77/100 and a GF Value™ of ₹1,616.31 (Modestly Overvalued). The stock has 9 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Balaji Amines's Research & Development for the three months ended in Mar. 2026 was ₹0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

Balaji Amines  (NSE:BALAMINES) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Balaji Amines Research & Development Related Terms

Balaji Amines Research & Development Historical Data

* Premium members only.

The historical data trend for Balaji Amines's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Balaji Amines Research & Development Chart

Balaji Amines Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.60 12.16 7.09 7.84 4.36

Balaji Amines Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:BALAMINES
77GF Score
Balaji Amines Ltd NSE:BALAMINES
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Balaji Amines Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0 Mil mean?
Balaji Amines (NSE:BALAMINES) has a Research & Development of ₹0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Balaji Amines and its competitors.
Is Balaji Amines' Research & Development too high?
Balaji Amines' current Research & Development is ₹0 Mil. Overall, Balaji Amines has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Balaji Amines' Research & Development compare to LIN and SHW?
Balaji Amines' Research & Development of ₹0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Chemicals company?
A good Research & Development depends on the Chemicals industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Balaji Amines and its competitors. Balaji Amines's current Research & Development is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Balaji Amines stock overvalued right now?
Based on GuruFocus' analysis, Balaji Amines (NSE:BALAMINES) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,616.31, compared to a current price of ₹1,989.00 — trading 23.1% above its estimated fair value. The current Research & Development is ₹0 Mil. Balaji Amines' overall GF Score™ is 77/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Balaji Amines (NSE:BALAMINES), the current Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Balaji Amines (NSE:BALAMINES) Overvalued in 2026?

Based on GuruFocus' analysis, Balaji Amines stock appears to be overvalued. The current stock price of ₹1,989.00 is trading 23.1% above its estimated GF Value™ of ₹1,616.31. GuruFocus considers Balaji Amines to be Modestly Overvalued.

Key valuation signals for NSE:BALAMINES:

  • Research & Development: ₹0 Mil
  • GF Value™: ₹1,616.31 vs. price of ₹1,989.00 (23.1% above fair value)
  • GF Score™: 77/100 with 9 warning signs

No single metric tells the full story. See the NSE:BALAMINES stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Balaji Amines Business Description

Other Exchanges 530999:India
Address Plot No. 47, Kavuri Hills, Balaji Bhawan, Behind Jubilee Ridge Hotel, Madhapur, Hyderabad, TG, IND, 500 003
Balaji Amines Ltd is engaged in the manufacture and sale of aliphatic amines, speciality chemicals, and their derivatives. The Company's manufacturing facilities operate through Distributed Control Systems (DCS), indigenous process technologies, and a Zero Liquid Discharge (ZLD) framework. The business operates through the Chemicals and Hotel segments, with the Chemicals segment generating maximum revenue. Its products include amines such as Mono Methyl Amine (MMA), Di-Methyl Amine (DMA) and others; speciality chemicals such as Morpholine, Acetonitrile (ACN), and others; and amine derivatives such as Mono-Methyl Amine Hydrochloride (MMA HCL), Di-Methyl Amine Hydrochloride (DMA HCL) and others. Geographically, the Company generates maximum revenue from India.
77GF Score

Get the complete analysis for NSE:BALAMINES

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,989.00
Price
₹1,616.31
GF Value